Pesquisar
Pharming Group NV
PHARAdicionar à lista de desejos
13.770USD
+0.050+0.36%
Fechamento 07/02, 13:00（ET）Cotações atrasadas em 15 min
0.00Valor de mercado
--P/L TTM
Mais detalhes de Pharming Group NV Empresa
Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.
Informações de Pharming Group NV
Código da empresaPHAR
Nome da EmpresaPharming Group NV
Data de listagemJul 02, 1998
CEOChouraqui (Fabrice)
Número de funcionários- -
Tipo de títulosDepository Receipt
Fim do ano fiscal- -
EndereçoDarwinweg 24
CidadeLEIDEN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísNetherlands
Código postal2333 CR
Telefone31715247400
Sitehttps://www.pharming.com/
Código da empresaPHAR
Data de listagemJul 02, 1998
CEOChouraqui (Fabrice)
Executivos da empresa Pharming Group NV
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Stephen (Steve) Toor
Mr. Stephen (Steve) Toor
Chief Commercial Officer
Chief Commercial Officer
--
--
Mrs. Mireille Sanders
Mrs. Mireille Sanders
Chief Operations Officer
Chief Operations Officer
--
--
Ms. Barbara Yanni
Ms. Barbara Yanni
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Mark J. Pykett, M.D., Ph.D.
Dr. Mark J. Pykett, M.D., Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Anurag Relan, M.D.
Dr. Anurag Relan, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Leonard Kruimer, CPA
Mr. Leonard Kruimer, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Jabine Van Der Meijs
Ms. Jabine Van Der Meijs
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Steven Baert
Mr. Steven Baert
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ruud Van Outersterp
Mr. Ruud Van Outersterp
Chief Ethics and Compliance Officer
Chief Ethics and Compliance Officer
--
--
Dr. Richard Peters, M.D., Ph.D.
Dr. Richard Peters, M.D., Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Stephen (Steve) Toor
Mr. Stephen (Steve) Toor
Chief Commercial Officer
Chief Commercial Officer
--
--
Mrs. Mireille Sanders
Mrs. Mireille Sanders
Chief Operations Officer
Chief Operations Officer
--
--
Ms. Barbara Yanni
Ms. Barbara Yanni
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Mark J. Pykett, M.D., Ph.D.
Dr. Mark J. Pykett, M.D., Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Anurag Relan, M.D.
Dr. Anurag Relan, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Leonard Kruimer, CPA
Mr. Leonard Kruimer, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Pharming Group NV?
Os cinco principais acionistas de Pharming Group NV são: Mr. Stephen (Steve) Toor
Quantas instituições possuem ações da Pharming Group NV (PHAR)?
Em 2026Q1, 22 instituições possuíam ações da Pharming Group NV, com valor de mercado aproximado de 135.73K, representando 0.19% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 61813.00.